Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 2, 2015

View Archived Issues

PCORI approves USD 83 million to fund patient-centered clinical effectiveness research studies

LDC and Infinity Pharmaceuticals to cooperate in oncology drug discovery and development

Novavax receives Gates Foundation grant to develop RSV vaccine; reports phase I and II results

Amydis Diagnostics awarded NIA-NIH grant for technology to detect Alzheimer's disease

Heraeus Medical and OrthoCyte agree to develop stem cell based bone graft product

Cloud Pharmaceuticals and THERAMetrics collaborate in orphan CNS diseases

Astellas and Chromocell sign license and collaboration agreement in neuropathic pain

Downregulation of lysyl oxidase prevents vascular lesions in diabetic retinopathy

Aspen Park Pharmaceuticals acquires drug to treat castration-resistant prostate cancer

Epicardial Fstl1 promotes cardiomyocyte regeneration after myocardial infarction

Naproxcinod superior to naproxen in mouse model of DMD

GSK exercises option to license inhaled therapeutics under Liquidia collaboration

The Leukemia & Lymphoma Society commits new funding to support cancer research

European Union funds 4SC research project EMTherapy

Phase III METEOR trial data: cabozantinib in advanced kidney cancer

Effect of TRL-1068 on biofilms

Bristol-Myers Squibb receives FDA approval for Opdivo + Yervoy in metastatic melanoma

XBiotech's 514G3 receives FDA fast track designation for serious infections

Seno Medical Instruments completes final phase of PIONEER study

Breast Cancer Awareness Month: Testing a new approach

Xoma licenses first-in-class anti-TGF-beta antibody program to Novartis

Amicus Therapeutics completes acquisition of Scioderm

Roche and Siena Biotech report BACE1 inhibitors

reMYND presents compounds for protein-misfolding disorders

Boehringer Ingelheim presents SYK inhibitors

Bayer presents new soluble guanylate cyclase activators

Otologic licenses sensory hair cell regeneration technology from Hough Ear Institute

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...